Alginic acid
- Generic Name
- Alginic acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9005-32-7
- Unique Ingredient Identifier
- 8C3Z4148WZ
- Background
Alginic acid, also referred to as algin or alginate, is a hydrophilic or anionic polysaccharide isolated from certain brown seaweed (Phacophycae) via alkaline extraction. It is present in cell walls of brown algae where it forms a viscous gel when binding with water. Alginic acid is a linear polymer consisted of L-glucuronic acid and D-mannuronic acid residu...
- Indication
Indicated for the management of gastric reflux, reflux oesophagitis, hiatus hernia, heartburn (including heartburn of pregnancy) and similar gastric distress .
- Associated Conditions
- Dyspepsia, Flatulence, Gastro-esophageal Reflux Disease (GERD), Gastroesophageal Reflux, Heartburn, Reflux Acid, Reflux Esophagitis (RE), Regurgitation
- Associated Therapies
- -
Fennec Pharmaceuticals Inc. Latest Stock News & Market Updates
Fennec Pharmaceuticals (FENC) is a commercial-stage biopharmaceutical company dedicated to developing cancer therapies, with a focus on pediatric oncology. Its lead product, PEDMARK, is a sodium thiosulfate formulation approved by the FDA to prevent cisplatin-induced hearing loss in pediatric patients. Recent developments include a licensing agreement with Norgine for PEDMARQSI commercialization in Europe, Australia, and New Zealand, and EU marketing authorization for PEDMARQSI.
Shield Therapeutics announces promising paediatric trial results.
Shield Therapeutics' FORTIS/ST10-01-305 trial showed significant efficacy, safety, and tolerability of its oral liquid suspension, leading to planned regulatory submissions to the US FDA and EMA for a paediatric indication in 2025. The study met all primary endpoints, demonstrating clinically relevant Hb level increases, with no treatment-related adverse events in the ferric maltol group. Shield expects to receive €1m development milestones from Norgine upon EMA approval.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath